These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
Portfolio Pulse from Avi Kapoor
Johnson & Johnson (NYSE:JNJ) reported better-than-expected Q2 earnings, with adjusted EPS of $2.82 and sales of $22.45 billion. The company raised its fiscal year 2024 operational sales guidance but lowered its adjusted EPS guidance. Analysts revised their price targets on JNJ following the announcement.
July 18, 2024 | 4:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson reported strong Q2 earnings, beating expectations with an adjusted EPS of $2.82 and sales of $22.45 billion. The company raised its fiscal year 2024 operational sales guidance but lowered its adjusted EPS guidance. Analysts revised their price targets, with mixed ratings.
The better-than-expected earnings and raised sales guidance are positive indicators for JNJ's stock. However, the lowered EPS guidance and mixed analyst ratings may temper the enthusiasm. Overall, the news is likely to have a positive short-term impact on the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100